$UPPR “This agreement with PrimaPharma, Inc., will expand the manufacturing capabilities of UPPR for commercial CBD products and further addresses the need for cGMP manufacturing and production standards needed for anticipated clinical studies by drug sponsors planning to file an IND (Investigational New Drug) application with the FDA to conduct clinical trials which will be required for the sponsor to make claims.” Joseph Earle, Upper Street President and CEO. https://finance.yahoo.com/news/upper-street-marketing-inc-announces-141500697.html
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.